The global fertility market is estimated to grow to ~$50B by 2030 with nearly 1/8 couples having trouble conceiving. Advances in technology are making reproductive health options more accessible from both a convenience and affordability standpoint. Bea Fertility is a healthcare startup offering at-home fertility treatments via a kit offered through subscription. Traditional fertility options like IVF need to be done at a fertility center and come at exorbitant cost. Bea uses ICI, a technique that’s similarly effective to other treatment options, but only costs £300/month. The company is focused on supporting the entire conception journey and offers ovulation tracking, guidance, and an expert network. Presently pre-launch, Bea is in the process of gaining regulatory approval and expects to launch by the end of the year. London TechWatch caught up with CEO and Cofounder Tess Cosad to learn more about the importance of making fertility treatments accessible, the company’s upcoming launch, strategic plans, and recent round of funding from Calm/Storm VC and QVentures.
London Tech News for the week ending 3/4 including the London startup fundings, exits, and events featuring news for Wi5, Manual, and much, much more.
The latest venture capital, seed, pre-seed, and angel deals for London startups for 2/4/2021 featuring funding details for Anima, Bea Fertility, and much more.